Beijing Stock Exchange 50 Index Hits 10-Month Low! Three Major Sectors See Significant Pullbacks, These Stocks Face Margin Client Selling Pressure

Cailian Press, March 17 (Editor: Zilong), Today (March 17), the Beijing Stock Exchange 50 Index was adjusted again, reaching its lowest point in nearly 10 months since June 2025. Currently, the Beijing Stock Exchange 50 Index has experienced four consecutive declines, with the year-to-date decline expanding to nearly 5.2%.

Note: The Beijing Stock Exchange 50 Index has been continuously declining recently (as of the close on March 17).

Component stocks review for the year, these sectors have seen significant pullbacks

Looking at the component stocks of the Beijing Stock Exchange 50, the 50 stocks have an average decline of 4.15% this year, with a median decline of 5.50%. Among them, 18 stocks have fallen more than 10% year-to-date, including Kaite Shares, Fengguang Precision, Jinbo Biotech, Junchuang Technology, Dingzhi Technology, and Wanda Bearings, with six stocks dropping over 20%. Among the major weighted stocks, Jinbo Biotech has experienced a notable decline of 22%, while Betterui and KaiFa Technology have fallen 7.4% and 6.2%, respectively.

Note: Performance of the top market cap component stocks of the Beijing Stock Exchange 50 this year (as of the close on March 17).

By industry sector (Shenwan Level 1), excluding sectors with only one stock, the nonferrous metals, electrical equipment, and basic chemicals sectors have performed relatively well, with gains of 4.8%, 4.5%, and 2.5%, respectively. Conversely, stocks from the automotive, machinery, and electronics sectors have performed poorly this year. Additionally, construction decoration, communications, computers, and biomedicine stocks have all experienced declines on average.

Note: Average year-to-date percentage change of Beijing Stock Exchange 50 component stocks by industry (as of March 17 close).

Looking at the overall market performance on the Beijing Stock Exchange this year, excluding the 11 newly listed stocks this year, the remaining nearly 290 stocks have an average decline of 3.4%, with a median decline of 5.3%, slightly better than the Beijing Stock Exchange 50 component stocks. Among them, Jinhui Medical, Jiahe Technology, and Henghe Shares have fallen over 30%. Conversely, stocks like Keli Shares, Yinneng Power, Liancheng CNC, Liqun Technology, and Zhongcheng Technology have performed countertrend, with Keli Shares and Yinneng Power being the only two stocks on the Beijing Stock Exchange to double in value this year.

Trading volume hits new lows this year, investor activity scan

From the volume data, the trading volume on the Beijing Stock Exchange has been continuously declining recently, with yesterday and today recording 14.781 billion yuan and 16.865 billion yuan, respectively—both the lowest and fifth-lowest in the year. Over the year, the Beijing Stock Exchange has had five trading days with daily turnover below 17 billion yuan, including February 24 (163.79 billion yuan), February 13 (164.37 billion yuan), and February 11 (165.50 billion yuan).

Note: Recent changes in trading volume on the Beijing Stock Exchange (as of the close on March 17).

In terms of capital, the financing balance on the Beijing Stock Exchange has shown a trend of rising and falling within the year. As of March 16, the total financing balance was nearly 8.443 billion yuan, an increase of about 480 million yuan from the end of last year, a growth of approximately 6.1%. Notably, on January 12, the sector saw a record high single-day net purchase of nearly 470 million yuan from investors. Conversely, on February 13, March 2, and January 16, the sector experienced relatively high net selling days.

Note: Recent changes in the financing balance of the Beijing Stock Exchange (as of March 16).

Regarding individual stocks, as of March 16, a total of 16 stocks had a net financing purchase amount exceeding 20 million yuan this year, with Liancheng CNC being the only one exceeding 100 million yuan. Stocks like Paralleling Technology, Kaide Quartz, and Keli Shares also saw significant investor buying, while Jinbo Biotech, Betterui, Tongli Shares, Deyuan Pharmaceuticals, and Jiaoda Iron and Steel saw heavy selling. In terms of financing control ratios, Haidaer exceeds 7%, with Audiwei, Kaide Quartz, and Litong Technology also having relatively high ratios.